27 Feb 2017 | 12:26 PM
 

Bliss GVS Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 506197 | NSE Symbol: BLISSGVS
152.31
-0.80
(-0.52 %)
27 Feb 2017 | 12:20 PM
Change company
  • Open (Rs)
    153.50
  • Prev. close (Rs.)
    153.10
  • High (Rs.)
    154.20
  • Low (Rs.)
    151.15
  • 52W H (Rs.)
    184.50
  • 52W L (Rs.)
    79.00
  • Volume (Rs.)
    19681
  • MCap (Rs in Cr.)
    1,570.93
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
8.00
Operating Margin (%)
28.39
Gross Profit Margin (%)
25.97
Net Profit Margin (%)
15.08
Total Debt/Equity
0.24
Dividend payout Ratio (Net Profit)
7.65
Earning Retention Ratio
93.70

News

22 Nov 2016 - 15:07:00-Bliss GVS Pharma's Kenyan arm has won a three-year contract worth USD 111...
10 Nov 2015 - 12:12:00-Leading pharmaceutical company Bliss GVS Pharma’s board has appointed Hira Sadhak as its indep...
03 Jul 2015 - 11:59:00-Shares of Bliss GVS Pharma rose 20 per cent in early trade on Bombay Stock Exchange (NSE) after the ...
03 Jul 2015 - 11:14:00-Manufacturer of wide range of Medical Products Bliss GVS Pharma Ltd has informed in a filing to BSE ...

Announcements

11-Feb-2017
Bliss GVS Pharma - Outcome of Board Meeting
10-Feb-2017
Bliss GVS Pharma - Standalone & Consolidated Financial Results Limited Review Report for December 31 2016
01-Feb-2017
Bliss GVS Pharma - Board Meeting Intimation for Results & Closure of Trading Window
17-Jan-2017
Bliss GVS Pharma - Shareholding for the Period Ended December 31 2016
17-Jan-2017
Bliss GVS Pharma - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Decemb

Religare Research

23 Feb 2017 | 06:00 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
23 Feb 2017 | 06:00 PM
Nifty index settled on a positive note for the fifth successive week, hitting 52 week high on the la...
23 Feb 2017 | 12:45 PM
VIP Industries (VIP) reported in-line numbers for Q3FY17 with a revenue and PAT growth of 5.5% & 43....
23 Feb 2017 | 11:15 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors60.16%
Mutual Funds/UTI0.00%
FI/Banks0.18%
Insurance0.18%
FII5.26%
Government0.00%
Others16.69%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,105.00(0.06)
11816
 Merck Ltd.
1,077.90(-0.91)
3302
 AstraZeneca Pharma India Ltd.
915.00(0.26)
3274
 Neuland Laboratories Ltd.
915.00(1.37)
3578

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bliss GVS Pharma Ltd.2.4524.7017.85
NIFTY(S&P CNX)530.60888.80289.50
BSE SENSEX1,777.052,842.58904.18
BSE 500752.721,322.78576.62

Corporate Details

Key Personal
Gautam R Ashra
Non Executive Director
Mayank S Mehta
Chairman & Ind.Director
S N Kamath
Managing Director
Key Address
Registered Office
102 Hyde Park Saki Vihar Road Andheri - East,Mumbai,Maharashtra

Tel:022-42160000, Fax:022-28563930

info@blissgvs.com
http://www.blissgvs.com
Registrar Office
Universal Capital Securities Pvt. Ltd.
Add. :21/25 Shakil Nivas Opp. Satya Saibaba Temple Mahakali Caves Road Andheri (East)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Bliss GVS Pharma Ltd. that will help you decide whether to buy, sell or hold Bliss GVS Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Bliss GVS Pharma Ltd.